Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (PICOV) A Multicentre Academic Prospective Cohort Study in Nursing Home During the Winter Season 2020-2021
Latest Information Update: 03 Apr 2023
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms PICOV
- 27 Mar 2023 Results (n=173)for individuals without evidence of previous SARS-CoV-2 infection at third dose administration , published in the Vaccine
- 27 Mar 2023 Status changed from recruiting to completed.
- 07 Jul 2022 Planned End Date changed from 30 May 2022 to 31 Oct 2022.